GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ERG
|
ENSG00000157554.14 | ETS transcription factor ERG |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ERG | hg19_v2_chr21_-_40033618_40033712, hg19_v2_chr21_-_39870339_39870443 | 0.30 | 4.6e-06 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr21_-_46340770 | 33.98 |
ENST00000397854.3
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr5_-_130970723 | 26.74 |
ENST00000308008.6
ENST00000296859.6 ENST00000507093.1 ENST00000510071.1 ENST00000509018.1 ENST00000307984.5 |
RAPGEF6
|
Rap guanine nucleotide exchange factor (GEF) 6 |
chr1_+_153330322 | 26.04 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chr11_+_1874200 | 25.88 |
ENST00000311604.3
|
LSP1
|
lymphocyte-specific protein 1 |
chr6_+_33048222 | 25.58 |
ENST00000428835.1
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr3_-_121379739 | 25.17 |
ENST00000428394.2
ENST00000314583.3 |
HCLS1
|
hematopoietic cell-specific Lyn substrate 1 |
chr21_-_46340884 | 25.14 |
ENST00000302347.5
ENST00000517819.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr19_-_51875894 | 24.11 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
chr1_-_153518270 | 21.08 |
ENST00000354332.4
ENST00000368716.4 |
S100A4
|
S100 calcium binding protein A4 |
chr3_-_128879875 | 19.85 |
ENST00000418265.1
ENST00000393292.3 ENST00000273541.8 |
ISY1-RAB43
ISY1
|
ISY1-RAB43 readthrough ISY1 splicing factor homolog (S. cerevisiae) |
chr1_+_10003486 | 19.64 |
ENST00000403197.1
ENST00000377205.1 |
NMNAT1
|
nicotinamide nucleotide adenylyltransferase 1 |
chr6_+_31553901 | 19.60 |
ENST00000418507.2
ENST00000438075.2 ENST00000376100.3 ENST00000376111.4 |
LST1
|
leukocyte specific transcript 1 |
chr11_-_71791518 | 19.22 |
ENST00000537217.1
ENST00000366394.3 ENST00000358965.6 ENST00000546131.1 ENST00000543937.1 ENST00000368959.5 ENST00000541641.1 |
NUMA1
|
nuclear mitotic apparatus protein 1 |
chr11_+_2421718 | 19.11 |
ENST00000380996.5
ENST00000333256.6 ENST00000380992.1 ENST00000437110.1 ENST00000435795.1 |
TSSC4
|
tumor suppressing subtransferable candidate 4 |
chr10_-_72362515 | 18.83 |
ENST00000373209.2
ENST00000441259.1 |
PRF1
|
perforin 1 (pore forming protein) |
chr11_+_313503 | 18.19 |
ENST00000528780.1
ENST00000328221.5 |
IFITM1
|
interferon induced transmembrane protein 1 |
chr11_-_71791726 | 18.01 |
ENST00000393695.3
|
NUMA1
|
nuclear mitotic apparatus protein 1 |
chr12_-_6798616 | 17.99 |
ENST00000355772.4
ENST00000417772.3 ENST00000396801.3 ENST00000396799.2 |
ZNF384
|
zinc finger protein 384 |
chr11_-_71791435 | 17.75 |
ENST00000351960.6
ENST00000541719.1 ENST00000535111.1 |
NUMA1
|
nuclear mitotic apparatus protein 1 |
chr6_-_33048483 | 17.63 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
chr6_-_33267101 | 17.63 |
ENST00000497454.1
|
RGL2
|
ral guanine nucleotide dissociation stimulator-like 2 |
chr11_-_64512273 | 16.95 |
ENST00000377497.3
ENST00000377487.1 ENST00000430645.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr19_-_36399149 | 16.92 |
ENST00000585901.2
ENST00000544690.2 ENST00000424586.3 ENST00000262629.4 ENST00000589517.1 |
TYROBP
|
TYRO protein tyrosine kinase binding protein |
chr8_-_21771214 | 16.57 |
ENST00000276420.4
|
DOK2
|
docking protein 2, 56kDa |
chr2_+_17935383 | 16.54 |
ENST00000524465.1
ENST00000381254.2 ENST00000532257.1 |
GEN1
|
GEN1 Holliday junction 5' flap endonuclease |
chr5_-_172198190 | 16.42 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
chr12_-_6798523 | 16.25 |
ENST00000319770.3
|
ZNF384
|
zinc finger protein 384 |
chr1_+_156698234 | 16.19 |
ENST00000368218.4
ENST00000368216.4 |
RRNAD1
|
ribosomal RNA adenine dimethylase domain containing 1 |
chr19_-_10450287 | 15.92 |
ENST00000589261.1
ENST00000590569.1 ENST00000589580.1 ENST00000589249.1 |
ICAM3
|
intercellular adhesion molecule 3 |
chr22_-_17680472 | 15.86 |
ENST00000330232.4
|
CECR1
|
cat eye syndrome chromosome region, candidate 1 |
chr17_-_76123101 | 15.80 |
ENST00000392467.3
|
TMC6
|
transmembrane channel-like 6 |
chr6_+_31553978 | 15.79 |
ENST00000376096.1
ENST00000376099.1 ENST00000376110.3 |
LST1
|
leukocyte specific transcript 1 |
chr12_+_69742121 | 15.63 |
ENST00000261267.2
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
chr1_-_25558984 | 15.48 |
ENST00000236273.4
|
SYF2
|
SYF2 pre-mRNA-splicing factor |
chr11_+_71791849 | 15.30 |
ENST00000423494.2
ENST00000539587.1 ENST00000538478.1 ENST00000324866.7 ENST00000439209.1 |
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing |
chr19_-_10450328 | 15.27 |
ENST00000160262.5
|
ICAM3
|
intercellular adhesion molecule 3 |
chr17_-_62097927 | 15.17 |
ENST00000578313.1
ENST00000584084.1 ENST00000579788.1 ENST00000579687.1 ENST00000578379.1 ENST00000578892.1 ENST00000412356.1 ENST00000418105.1 |
ICAM2
|
intercellular adhesion molecule 2 |
chr8_+_117778736 | 14.90 |
ENST00000309822.2
ENST00000357148.3 ENST00000517814.1 ENST00000517820.1 |
UTP23
|
UTP23, small subunit (SSU) processome component, homolog (yeast) |
chr20_-_48532019 | 14.89 |
ENST00000289431.5
|
SPATA2
|
spermatogenesis associated 2 |
chr6_+_111580508 | 14.77 |
ENST00000368847.4
|
KIAA1919
|
KIAA1919 |
chr11_-_46722117 | 14.68 |
ENST00000311956.4
|
ARHGAP1
|
Rho GTPase activating protein 1 |
chr12_-_6798410 | 14.67 |
ENST00000361959.3
ENST00000436774.2 ENST00000544482.1 |
ZNF384
|
zinc finger protein 384 |
chr1_-_36937075 | 14.66 |
ENST00000464465.2
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
chr11_+_46722368 | 14.66 |
ENST00000311764.2
|
ZNF408
|
zinc finger protein 408 |
chr2_-_136873735 | 14.62 |
ENST00000409817.1
|
CXCR4
|
chemokine (C-X-C motif) receptor 4 |
chr12_+_7055767 | 14.52 |
ENST00000447931.2
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr2_+_103035102 | 14.43 |
ENST00000264260.2
|
IL18RAP
|
interleukin 18 receptor accessory protein |
chr11_+_71791693 | 14.32 |
ENST00000289488.2
ENST00000447974.1 |
LRTOMT
|
leucine rich transmembrane and O-methyltransferase domain containing |
chr19_+_1077393 | 14.30 |
ENST00000590577.1
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr19_+_58694396 | 14.28 |
ENST00000326804.4
ENST00000345813.3 ENST00000424679.2 |
ZNF274
|
zinc finger protein 274 |
chr16_+_30483962 | 14.28 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr3_-_15469006 | 14.27 |
ENST00000443029.1
ENST00000383790.3 ENST00000383789.5 |
METTL6
|
methyltransferase like 6 |
chr3_-_48936272 | 14.26 |
ENST00000544097.1
ENST00000430379.1 ENST00000319017.4 |
SLC25A20
|
solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 |
chr5_+_67584174 | 14.17 |
ENST00000320694.8
|
PIK3R1
|
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
chrY_+_2709906 | 14.06 |
ENST00000430575.1
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
chr17_-_37844267 | 13.97 |
ENST00000579146.1
ENST00000378011.4 ENST00000429199.2 ENST00000300658.4 |
PGAP3
|
post-GPI attachment to proteins 3 |
chr6_+_31620191 | 13.96 |
ENST00000375918.2
ENST00000375920.4 |
APOM
|
apolipoprotein M |
chr11_-_64885111 | 13.81 |
ENST00000528598.1
ENST00000310597.4 |
ZNHIT2
|
zinc finger, HIT-type containing 2 |
chr19_-_56632592 | 13.75 |
ENST00000587279.1
ENST00000270459.3 |
ZNF787
|
zinc finger protein 787 |
chr1_+_161185032 | 13.58 |
ENST00000367992.3
ENST00000289902.1 |
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
chr12_-_6233828 | 13.57 |
ENST00000572068.1
ENST00000261405.5 |
VWF
|
von Willebrand factor |
chr2_-_96811170 | 13.55 |
ENST00000288943.4
|
DUSP2
|
dual specificity phosphatase 2 |
chr19_+_16296191 | 13.43 |
ENST00000589852.1
ENST00000263384.7 ENST00000588367.1 ENST00000587351.1 |
FAM32A
|
family with sequence similarity 32, member A |
chr1_+_156698708 | 13.43 |
ENST00000519086.1
|
RRNAD1
|
ribosomal RNA adenine dimethylase domain containing 1 |
chrY_+_2709527 | 13.32 |
ENST00000250784.8
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
chr12_-_15114603 | 13.27 |
ENST00000228945.4
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr20_-_4795747 | 13.22 |
ENST00000379376.2
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr19_+_56186557 | 13.04 |
ENST00000270460.6
|
EPN1
|
epsin 1 |
chr17_-_62084241 | 13.02 |
ENST00000449662.2
|
ICAM2
|
intercellular adhesion molecule 2 |
chr15_+_71185148 | 12.90 |
ENST00000443425.2
ENST00000560755.1 |
LRRC49
|
leucine rich repeat containing 49 |
chr12_+_7055631 | 12.87 |
ENST00000543115.1
ENST00000399448.1 |
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
chr14_+_100594914 | 12.86 |
ENST00000554695.1
|
EVL
|
Enah/Vasp-like |
chrX_-_107018969 | 12.79 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
chr17_+_72462766 | 12.77 |
ENST00000392625.3
ENST00000361933.3 ENST00000310828.5 |
CD300A
|
CD300a molecule |
chr11_-_59950622 | 12.71 |
ENST00000323961.3
ENST00000412309.2 |
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A |
chr3_-_18480260 | 12.67 |
ENST00000454909.2
|
SATB1
|
SATB homeobox 1 |
chr4_+_153701081 | 12.62 |
ENST00000451320.2
ENST00000429148.2 ENST00000353617.2 ENST00000405727.2 ENST00000356064.3 |
ARFIP1
|
ADP-ribosylation factor interacting protein 1 |
chr17_-_29641084 | 12.60 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
chr17_-_29641104 | 12.42 |
ENST00000577894.1
ENST00000330927.4 |
EVI2B
|
ecotropic viral integration site 2B |
chr22_+_23247030 | 12.35 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr7_-_76829125 | 12.22 |
ENST00000248598.5
|
FGL2
|
fibrinogen-like 2 |
chr4_+_2814011 | 12.19 |
ENST00000502260.1
ENST00000435136.2 |
SH3BP2
|
SH3-domain binding protein 2 |
chr1_-_20834586 | 12.18 |
ENST00000264198.3
|
MUL1
|
mitochondrial E3 ubiquitin protein ligase 1 |
chr14_-_81687197 | 12.04 |
ENST00000553612.1
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr14_+_100842735 | 11.94 |
ENST00000554998.1
ENST00000402312.3 ENST00000335290.6 ENST00000554175.1 |
WDR25
|
WD repeat domain 25 |
chr22_+_17565841 | 11.93 |
ENST00000319363.6
|
IL17RA
|
interleukin 17 receptor A |
chr12_-_15114492 | 11.89 |
ENST00000541546.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr17_-_62097904 | 11.87 |
ENST00000583366.1
|
ICAM2
|
intercellular adhesion molecule 2 |
chr14_+_100531615 | 11.80 |
ENST00000392920.3
|
EVL
|
Enah/Vasp-like |
chr14_-_81687575 | 11.77 |
ENST00000434192.2
|
GTF2A1
|
general transcription factor IIA, 1, 19/37kDa |
chr19_+_47759716 | 11.75 |
ENST00000221922.6
|
CCDC9
|
coiled-coil domain containing 9 |
chr22_-_37640456 | 11.71 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr16_-_31214051 | 11.57 |
ENST00000350605.4
|
PYCARD
|
PYD and CARD domain containing |
chr22_+_23165153 | 11.50 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr17_+_1674982 | 11.44 |
ENST00000572048.1
ENST00000573763.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
chr19_+_55141861 | 11.42 |
ENST00000396327.3
ENST00000324602.7 ENST00000434867.2 |
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr1_-_111746966 | 11.41 |
ENST00000369752.5
|
DENND2D
|
DENN/MADD domain containing 2D |
chr15_+_71184931 | 11.40 |
ENST00000560369.1
ENST00000260382.5 |
LRRC49
|
leucine rich repeat containing 49 |
chr10_+_75545391 | 11.33 |
ENST00000604524.1
ENST00000605216.1 ENST00000398706.2 |
ZSWIM8
|
zinc finger, SWIM-type containing 8 |
chr11_-_417308 | 11.32 |
ENST00000397632.3
ENST00000382520.2 |
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr14_-_94856987 | 11.30 |
ENST00000449399.3
ENST00000404814.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr1_-_167487808 | 11.27 |
ENST00000392122.3
|
CD247
|
CD247 molecule |
chr19_+_40854559 | 11.12 |
ENST00000598962.1
ENST00000409419.1 ENST00000409587.1 ENST00000602131.1 ENST00000409735.4 ENST00000600948.1 ENST00000356508.5 ENST00000596682.1 ENST00000594908.1 |
PLD3
|
phospholipase D family, member 3 |
chr16_+_30484021 | 11.12 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr15_+_74833518 | 11.10 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
chr1_+_209929377 | 11.00 |
ENST00000400959.3
ENST00000367025.3 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr3_+_47324424 | 10.97 |
ENST00000437353.1
ENST00000232766.5 ENST00000455924.2 |
KLHL18
|
kelch-like family member 18 |
chr14_+_92980111 | 10.96 |
ENST00000216487.7
ENST00000557762.1 |
RIN3
|
Ras and Rab interactor 3 |
chr14_-_24711865 | 10.95 |
ENST00000399423.4
ENST00000267415.7 |
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2 |
chr15_+_77287426 | 10.92 |
ENST00000558012.1
ENST00000267939.5 ENST00000379595.3 |
PSTPIP1
|
proline-serine-threonine phosphatase interacting protein 1 |
chr1_+_198608146 | 10.87 |
ENST00000367376.2
ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
chr10_+_75545329 | 10.86 |
ENST00000604729.1
ENST00000603114.1 |
ZSWIM8
|
zinc finger, SWIM-type containing 8 |
chr17_-_79269067 | 10.85 |
ENST00000288439.5
ENST00000374759.3 |
SLC38A10
|
solute carrier family 38, member 10 |
chr14_-_94857004 | 10.84 |
ENST00000557492.1
ENST00000448921.1 ENST00000437397.1 ENST00000355814.4 ENST00000393088.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr20_+_62612470 | 10.83 |
ENST00000266079.4
ENST00000535781.1 |
PRPF6
|
pre-mRNA processing factor 6 |
chr14_-_94856951 | 10.76 |
ENST00000553327.1
ENST00000556955.1 ENST00000557118.1 ENST00000440909.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
chr11_-_60719213 | 10.69 |
ENST00000227880.3
|
SLC15A3
|
solute carrier family 15 (oligopeptide transporter), member 3 |
chr14_+_24583836 | 10.66 |
ENST00000559115.1
ENST00000558215.1 ENST00000557810.1 ENST00000561375.1 ENST00000446197.3 ENST00000559796.1 ENST00000560713.1 ENST00000560901.1 ENST00000559382.1 |
DCAF11
|
DDB1 and CUL4 associated factor 11 |
chr2_-_69870747 | 10.65 |
ENST00000409068.1
|
AAK1
|
AP2 associated kinase 1 |
chr1_-_183559693 | 10.64 |
ENST00000367535.3
ENST00000413720.1 ENST00000418089.1 |
NCF2
|
neutrophil cytosolic factor 2 |
chr1_+_228353495 | 10.64 |
ENST00000366711.3
|
IBA57
|
IBA57, iron-sulfur cluster assembly homolog (S. cerevisiae) |
chr1_+_209929494 | 10.63 |
ENST00000367026.3
|
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr5_-_180236811 | 10.63 |
ENST00000446023.2
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
chr11_-_417388 | 10.58 |
ENST00000332725.3
|
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
chr1_+_1260147 | 10.57 |
ENST00000343938.4
|
GLTPD1
|
glycolipid transfer protein domain containing 1 |
chr1_-_167487758 | 10.55 |
ENST00000362089.5
|
CD247
|
CD247 molecule |
chr14_+_75746781 | 10.54 |
ENST00000555347.1
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog |
chr14_-_24711806 | 10.53 |
ENST00000540705.1
ENST00000538777.1 ENST00000558566.1 ENST00000559019.1 |
TINF2
|
TERF1 (TRF1)-interacting nuclear factor 2 |
chr11_-_59950519 | 10.48 |
ENST00000528851.1
|
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A |
chr8_-_21771182 | 10.46 |
ENST00000523932.1
ENST00000544659.1 |
DOK2
|
docking protein 2, 56kDa |
chr4_-_156875003 | 10.45 |
ENST00000433477.3
|
CTSO
|
cathepsin O |
chr2_+_54198210 | 10.43 |
ENST00000607452.1
ENST00000422521.2 |
ACYP2
|
acylphosphatase 2, muscle type |
chr20_-_44993012 | 10.34 |
ENST00000372229.1
ENST00000372230.5 ENST00000543605.1 ENST00000243896.2 ENST00000317734.8 |
SLC35C2
|
solute carrier family 35 (GDP-fucose transporter), member C2 |
chr7_+_150264365 | 10.30 |
ENST00000255945.2
ENST00000461940.1 |
GIMAP4
|
GTPase, IMAP family member 4 |
chr1_-_150738261 | 10.26 |
ENST00000448301.2
ENST00000368985.3 |
CTSS
|
cathepsin S |
chr20_+_49575342 | 10.23 |
ENST00000244051.1
|
MOCS3
|
molybdenum cofactor synthesis 3 |
chr1_-_183560011 | 10.23 |
ENST00000367536.1
|
NCF2
|
neutrophil cytosolic factor 2 |
chr6_-_112080256 | 10.23 |
ENST00000462856.2
ENST00000229471.4 |
FYN
|
FYN oncogene related to SRC, FGR, YES |
chr11_-_59950486 | 10.19 |
ENST00000426738.2
ENST00000533023.1 ENST00000420732.2 |
MS4A6A
|
membrane-spanning 4-domains, subfamily A, member 6A |
chr11_-_64512803 | 10.18 |
ENST00000377489.1
ENST00000354024.3 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
chr5_-_131892501 | 10.16 |
ENST00000450655.1
|
IL5
|
interleukin 5 (colony-stimulating factor, eosinophil) |
chr17_-_18218237 | 10.12 |
ENST00000542570.1
|
TOP3A
|
topoisomerase (DNA) III alpha |
chr22_+_22020273 | 10.12 |
ENST00000412327.1
ENST00000335025.8 ENST00000398831.3 ENST00000492445.2 ENST00000458567.1 ENST00000406385.1 |
PPIL2
|
peptidylprolyl isomerase (cyclophilin)-like 2 |
chr17_+_4843679 | 10.11 |
ENST00000576229.1
|
RNF167
|
ring finger protein 167 |
chr3_+_15468862 | 10.10 |
ENST00000396842.2
|
EAF1
|
ELL associated factor 1 |
chr17_-_18218270 | 10.06 |
ENST00000321105.5
|
TOP3A
|
topoisomerase (DNA) III alpha |
chr1_+_32716840 | 10.06 |
ENST00000336890.5
|
LCK
|
lymphocyte-specific protein tyrosine kinase |
chr19_+_56186606 | 10.04 |
ENST00000085079.7
|
EPN1
|
epsin 1 |
chrX_+_128913906 | 9.94 |
ENST00000356892.3
|
SASH3
|
SAM and SH3 domain containing 3 |
chr22_-_38245304 | 9.86 |
ENST00000609454.1
|
ANKRD54
|
ankyrin repeat domain 54 |
chr1_-_153517473 | 9.82 |
ENST00000368715.1
|
S100A4
|
S100 calcium binding protein A4 |
chr19_+_50879705 | 9.80 |
ENST00000598168.1
ENST00000411902.2 ENST00000253727.5 ENST00000597790.1 ENST00000597130.1 ENST00000599105.1 |
NR1H2
|
nuclear receptor subfamily 1, group H, member 2 |
chr7_+_156742399 | 9.78 |
ENST00000275820.3
|
NOM1
|
nucleolar protein with MIF4G domain 1 |
chr16_-_88717482 | 9.77 |
ENST00000261623.3
|
CYBA
|
cytochrome b-245, alpha polypeptide |
chr1_+_24969755 | 9.74 |
ENST00000447431.2
ENST00000374389.4 |
SRRM1
|
serine/arginine repetitive matrix 1 |
chr12_-_51717948 | 9.73 |
ENST00000267012.4
|
BIN2
|
bridging integrator 2 |
chr21_+_45432174 | 9.72 |
ENST00000380221.3
ENST00000291574.4 |
TRAPPC10
|
trafficking protein particle complex 10 |
chr1_+_169337172 | 9.71 |
ENST00000367807.3
ENST00000367808.3 ENST00000329281.2 ENST00000420531.1 |
BLZF1
|
basic leucine zipper nuclear factor 1 |
chr12_-_51717875 | 9.69 |
ENST00000604560.1
|
BIN2
|
bridging integrator 2 |
chr11_+_5710919 | 9.68 |
ENST00000379965.3
ENST00000425490.1 |
TRIM22
|
tripartite motif containing 22 |
chr2_-_238322770 | 9.68 |
ENST00000472056.1
|
COL6A3
|
collagen, type VI, alpha 3 |
chr20_-_35580240 | 9.64 |
ENST00000262878.4
|
SAMHD1
|
SAM domain and HD domain 1 |
chr12_+_9102632 | 9.62 |
ENST00000539240.1
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1 |
chr19_+_48248779 | 9.60 |
ENST00000246802.5
|
GLTSCR2
|
glioma tumor suppressor candidate region gene 2 |
chr3_+_122044084 | 9.58 |
ENST00000264474.3
ENST00000479204.1 |
CSTA
|
cystatin A (stefin A) |
chr4_-_926069 | 9.58 |
ENST00000314167.4
ENST00000502656.1 |
GAK
|
cyclin G associated kinase |
chr18_-_47813940 | 9.51 |
ENST00000586837.1
ENST00000412036.2 ENST00000589940.1 |
CXXC1
|
CXXC finger protein 1 |
chr13_-_46756351 | 9.50 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr3_-_101232019 | 9.49 |
ENST00000394095.2
ENST00000394091.1 ENST00000394094.2 ENST00000358203.3 ENST00000348610.3 ENST00000314261.7 |
SENP7
|
SUMO1/sentrin specific peptidase 7 |
chr7_+_108210012 | 9.48 |
ENST00000249356.3
|
DNAJB9
|
DnaJ (Hsp40) homolog, subfamily B, member 9 |
chr1_-_160001737 | 9.45 |
ENST00000368090.2
|
PIGM
|
phosphatidylinositol glycan anchor biosynthesis, class M |
chr21_-_38639601 | 9.40 |
ENST00000539844.1
ENST00000476950.1 ENST00000399001.1 |
DSCR3
|
Down syndrome critical region gene 3 |
chr11_-_62389449 | 9.40 |
ENST00000534026.1
|
B3GAT3
|
beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) |
chr8_-_134309823 | 9.37 |
ENST00000414097.2
|
NDRG1
|
N-myc downstream regulated 1 |
chr19_+_55141948 | 9.36 |
ENST00000396332.4
ENST00000427581.2 |
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr2_-_238322800 | 9.35 |
ENST00000392004.3
ENST00000433762.1 ENST00000347401.3 ENST00000353578.4 ENST00000346358.4 ENST00000392003.2 |
COL6A3
|
collagen, type VI, alpha 3 |
chr8_+_38585704 | 9.33 |
ENST00000519416.1
ENST00000520615.1 |
TACC1
|
transforming, acidic coiled-coil containing protein 1 |
chr12_-_51717922 | 9.32 |
ENST00000452142.2
|
BIN2
|
bridging integrator 2 |
chr17_+_4843654 | 9.31 |
ENST00000575111.1
|
RNF167
|
ring finger protein 167 |
chr5_-_39274617 | 9.30 |
ENST00000510188.1
|
FYB
|
FYN binding protein |
chr20_-_23066953 | 9.30 |
ENST00000246006.4
|
CD93
|
CD93 molecule |
chr2_+_69001913 | 9.30 |
ENST00000409030.3
ENST00000409220.1 |
ARHGAP25
|
Rho GTPase activating protein 25 |
chr19_+_49838653 | 9.24 |
ENST00000598095.1
ENST00000426897.2 ENST00000323906.4 ENST00000535669.2 ENST00000597602.1 ENST00000595660.1 |
CD37
|
CD37 molecule |
chr8_+_144373550 | 9.24 |
ENST00000330143.3
ENST00000521537.1 ENST00000518432.1 ENST00000520333.1 |
ZNF696
|
zinc finger protein 696 |
chr14_+_23299088 | 9.22 |
ENST00000355151.5
ENST00000397496.3 ENST00000555345.1 ENST00000432849.3 ENST00000553711.1 ENST00000556465.1 ENST00000397505.2 ENST00000557221.1 ENST00000311892.6 ENST00000556840.1 ENST00000555536.1 |
MRPL52
|
mitochondrial ribosomal protein L52 |
chr11_-_61129335 | 9.19 |
ENST00000545361.1
ENST00000539128.1 ENST00000546151.1 ENST00000447532.2 |
CYB561A3
|
cytochrome b561 family, member A3 |
chr15_+_75074410 | 9.18 |
ENST00000439220.2
|
CSK
|
c-src tyrosine kinase |
chr19_+_18942761 | 9.15 |
ENST00000599848.1
|
UPF1
|
UPF1 regulator of nonsense transcripts homolog (yeast) |
chr22_+_37257015 | 9.09 |
ENST00000447071.1
ENST00000248899.6 ENST00000397147.4 |
NCF4
|
neutrophil cytosolic factor 4, 40kDa |
chr18_-_47807829 | 9.05 |
ENST00000585672.1
ENST00000457839.2 ENST00000353909.3 ENST00000339998.6 ENST00000398493.1 |
MBD1
|
methyl-CpG binding domain protein 1 |
chr17_-_79818354 | 9.04 |
ENST00000576541.1
ENST00000576380.1 ENST00000571617.1 ENST00000576052.1 ENST00000576390.1 ENST00000573778.2 ENST00000439918.2 ENST00000574914.1 ENST00000331483.4 |
P4HB
|
prolyl 4-hydroxylase, beta polypeptide |
chr14_+_21249200 | 9.00 |
ENST00000304677.2
|
RNASE6
|
ribonuclease, RNase A family, k6 |
chr5_+_156696362 | 8.91 |
ENST00000377576.3
|
CYFIP2
|
cytoplasmic FMR1 interacting protein 2 |
chr3_-_39321512 | 8.91 |
ENST00000399220.2
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1 |
chr21_-_38639813 | 8.90 |
ENST00000309117.6
ENST00000398998.1 |
DSCR3
|
Down syndrome critical region gene 3 |
chr19_+_3178736 | 8.89 |
ENST00000246115.3
|
S1PR4
|
sphingosine-1-phosphate receptor 4 |
chr15_+_81589254 | 8.89 |
ENST00000394652.2
|
IL16
|
interleukin 16 |
chr1_+_158801095 | 8.86 |
ENST00000368141.4
|
MNDA
|
myeloid cell nuclear differentiation antigen |
chr13_+_31191920 | 8.84 |
ENST00000255304.4
|
USPL1
|
ubiquitin specific peptidase like 1 |
chr4_-_926161 | 8.84 |
ENST00000511163.1
|
GAK
|
cyclin G associated kinase |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.3 | 55.0 | GO:1902365 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
9.0 | 26.9 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
8.8 | 26.5 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
8.5 | 25.4 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
8.0 | 8.0 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
6.3 | 25.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
6.1 | 24.6 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
6.1 | 18.4 | GO:1905224 | clathrin-coated pit assembly(GO:1905224) |
5.4 | 16.3 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
5.4 | 16.2 | GO:0033023 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
5.2 | 20.8 | GO:0002290 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
5.1 | 30.7 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
5.0 | 35.1 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
5.0 | 19.9 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
4.8 | 14.3 | GO:0039650 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
4.7 | 4.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
4.4 | 17.6 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
4.0 | 15.9 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
3.9 | 11.6 | GO:0034227 | tRNA thio-modification(GO:0034227) |
3.9 | 11.6 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
3.8 | 37.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
3.7 | 3.7 | GO:0009826 | unidimensional cell growth(GO:0009826) |
3.6 | 10.9 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
3.6 | 3.6 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
3.5 | 14.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
3.5 | 17.6 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
3.5 | 14.0 | GO:0034444 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
3.4 | 10.3 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
3.4 | 20.5 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
3.4 | 10.2 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
3.4 | 3.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
3.3 | 16.4 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) |
3.3 | 6.6 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
3.2 | 12.9 | GO:2000314 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
3.2 | 25.5 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
3.1 | 15.6 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
3.1 | 9.3 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
3.1 | 12.4 | GO:1904327 | maintenance of unfolded protein(GO:0036506) protein localization to cytosolic proteasome complex(GO:1904327) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
3.1 | 9.2 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
3.1 | 9.2 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
3.0 | 54.6 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
3.0 | 3.0 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
3.0 | 6.0 | GO:0070668 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
3.0 | 3.0 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
3.0 | 14.9 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
3.0 | 8.9 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
2.9 | 5.8 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
2.9 | 8.8 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
2.9 | 20.4 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
2.9 | 8.7 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
2.9 | 17.3 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
2.8 | 16.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
2.8 | 19.7 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
2.7 | 13.7 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
2.7 | 2.7 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
2.7 | 8.1 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) regulation of lactation(GO:1903487) |
2.7 | 10.8 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
2.6 | 7.9 | GO:0007439 | ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
2.6 | 7.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
2.6 | 2.6 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
2.6 | 7.8 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
2.6 | 7.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
2.6 | 12.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
2.6 | 2.6 | GO:0044010 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
2.5 | 10.1 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
2.5 | 2.5 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
2.5 | 17.3 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
2.4 | 12.2 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
2.4 | 21.4 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
2.4 | 14.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
2.4 | 11.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
2.4 | 4.7 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
2.4 | 7.1 | GO:1902769 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
2.4 | 16.5 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
2.3 | 21.1 | GO:0006531 | aspartate metabolic process(GO:0006531) |
2.3 | 6.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
2.3 | 36.2 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
2.2 | 6.7 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
2.2 | 15.5 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
2.2 | 8.8 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
2.2 | 26.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
2.2 | 15.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
2.2 | 10.9 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) bone marrow development(GO:0048539) |
2.2 | 6.5 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
2.2 | 6.5 | GO:1990502 | dense core granule maturation(GO:1990502) |
2.1 | 8.6 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) |
2.1 | 8.5 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
2.1 | 8.5 | GO:0019086 | late viral transcription(GO:0019086) |
2.1 | 8.4 | GO:0002884 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of hypersensitivity(GO:0002884) |
2.1 | 2.1 | GO:0002442 | serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
2.0 | 20.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
2.0 | 6.1 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
2.0 | 16.1 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
2.0 | 2.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
1.9 | 3.9 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
1.9 | 15.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
1.9 | 26.9 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
1.9 | 21.1 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
1.9 | 7.5 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.9 | 20.7 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
1.9 | 3.7 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
1.9 | 1.9 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
1.9 | 29.7 | GO:0045730 | respiratory burst(GO:0045730) |
1.9 | 3.7 | GO:0002384 | hepatic immune response(GO:0002384) |
1.8 | 3.7 | GO:2000439 | positive regulation of monocyte extravasation(GO:2000439) |
1.8 | 34.4 | GO:0060117 | auditory receptor cell development(GO:0060117) |
1.8 | 5.3 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
1.8 | 19.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
1.8 | 5.3 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.8 | 10.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.7 | 26.2 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
1.7 | 5.2 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
1.7 | 5.2 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
1.7 | 13.8 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
1.7 | 20.6 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
1.7 | 8.6 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
1.7 | 25.5 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
1.7 | 5.1 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
1.7 | 25.3 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
1.7 | 25.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
1.7 | 5.0 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
1.7 | 3.4 | GO:0051106 | positive regulation of DNA ligation(GO:0051106) |
1.7 | 10.0 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
1.7 | 3.3 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
1.7 | 8.3 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
1.7 | 6.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.6 | 9.9 | GO:2000400 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
1.6 | 4.9 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
1.6 | 4.9 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
1.6 | 1.6 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.6 | 4.8 | GO:0019417 | sulfur oxidation(GO:0019417) |
1.6 | 1.6 | GO:0051683 | Golgi localization(GO:0051645) establishment of Golgi localization(GO:0051683) |
1.6 | 9.6 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
1.6 | 3.2 | GO:0032079 | positive regulation of endodeoxyribonuclease activity(GO:0032079) |
1.6 | 4.8 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
1.6 | 7.9 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
1.6 | 4.7 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
1.6 | 3.2 | GO:0070426 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
1.6 | 24.8 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
1.5 | 3.0 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.5 | 4.5 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
1.5 | 4.5 | GO:0009078 | alanine metabolic process(GO:0006522) alanine catabolic process(GO:0006524) pyruvate family amino acid metabolic process(GO:0009078) pyruvate family amino acid catabolic process(GO:0009080) |
1.5 | 6.0 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
1.5 | 13.4 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
1.5 | 11.7 | GO:1901538 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
1.5 | 4.4 | GO:0060151 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
1.4 | 11.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
1.4 | 4.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
1.4 | 1.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.4 | 2.9 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
1.4 | 14.2 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.4 | 1.4 | GO:1902532 | negative regulation of intracellular signal transduction(GO:1902532) |
1.4 | 23.6 | GO:0006265 | DNA topological change(GO:0006265) |
1.4 | 23.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
1.4 | 22.1 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
1.4 | 2.7 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
1.4 | 8.1 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
1.4 | 12.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
1.3 | 10.8 | GO:0006013 | mannose metabolic process(GO:0006013) |
1.3 | 2.7 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
1.3 | 2.7 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.3 | 2.6 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
1.3 | 6.5 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) regulation of peroxidase activity(GO:2000468) positive regulation of peroxidase activity(GO:2000470) |
1.3 | 3.9 | GO:0035900 | response to isolation stress(GO:0035900) |
1.3 | 33.9 | GO:0071800 | podosome assembly(GO:0071800) |
1.3 | 3.9 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
1.3 | 9.0 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
1.3 | 5.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
1.3 | 10.2 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
1.3 | 10.2 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.3 | 12.7 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
1.3 | 3.8 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
1.3 | 6.3 | GO:2000843 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
1.3 | 15.0 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
1.2 | 5.0 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
1.2 | 2.5 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
1.2 | 7.5 | GO:0035984 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.2 | 3.7 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
1.2 | 2.4 | GO:0034128 | negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
1.2 | 9.7 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
1.2 | 9.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
1.2 | 6.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.2 | 2.4 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
1.2 | 2.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.2 | 3.5 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
1.2 | 1.2 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
1.2 | 1.2 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
1.2 | 25.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
1.2 | 7.0 | GO:0060613 | fat pad development(GO:0060613) |
1.2 | 3.5 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
1.2 | 11.6 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
1.1 | 2.3 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
1.1 | 16.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
1.1 | 3.4 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
1.1 | 4.5 | GO:0010193 | response to ozone(GO:0010193) |
1.1 | 7.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.1 | 5.6 | GO:0019835 | cytolysis(GO:0019835) |
1.1 | 4.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
1.1 | 3.4 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
1.1 | 4.4 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
1.1 | 5.5 | GO:1900920 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
1.1 | 5.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
1.1 | 8.8 | GO:0016926 | protein desumoylation(GO:0016926) |
1.1 | 11.0 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
1.1 | 3.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.1 | 3.3 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
1.1 | 11.0 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
1.1 | 4.4 | GO:0032053 | ciliary basal body organization(GO:0032053) |
1.1 | 8.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
1.1 | 7.6 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
1.1 | 6.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
1.1 | 7.6 | GO:0007000 | nucleolus organization(GO:0007000) |
1.1 | 4.3 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
1.1 | 4.2 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
1.1 | 11.6 | GO:0010224 | response to UV-B(GO:0010224) |
1.1 | 9.5 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
1.1 | 6.3 | GO:0097084 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) vascular smooth muscle cell development(GO:0097084) |
1.0 | 5.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
1.0 | 1.0 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
1.0 | 3.1 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
1.0 | 11.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
1.0 | 2.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.0 | 2.1 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
1.0 | 2.0 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
1.0 | 6.1 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
1.0 | 3.0 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
1.0 | 3.0 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) negative regulation of bicellular tight junction assembly(GO:1903347) |
1.0 | 16.2 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
1.0 | 4.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
1.0 | 25.9 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
1.0 | 7.9 | GO:0042098 | T cell proliferation(GO:0042098) |
1.0 | 4.0 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
1.0 | 4.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
1.0 | 4.0 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
1.0 | 10.9 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
1.0 | 4.9 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
1.0 | 1.0 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
1.0 | 5.9 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
1.0 | 8.7 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
1.0 | 17.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.0 | 5.8 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
1.0 | 5.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
1.0 | 3.8 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
1.0 | 3.8 | GO:0035411 | catenin import into nucleus(GO:0035411) |
1.0 | 73.2 | GO:0032945 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
0.9 | 19.9 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.9 | 0.9 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.9 | 2.8 | GO:1990168 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.9 | 6.6 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.9 | 5.6 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.9 | 1.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.9 | 57.0 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.9 | 3.7 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.9 | 4.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.9 | 7.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.9 | 2.7 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.9 | 2.7 | GO:0051697 | protein delipidation(GO:0051697) |
0.9 | 3.7 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.9 | 3.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.9 | 6.3 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.9 | 18.0 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.9 | 2.7 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.9 | 10.8 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.9 | 8.1 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.9 | 8.9 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.9 | 5.3 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.9 | 14.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.9 | 3.5 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.9 | 4.4 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.9 | 5.3 | GO:1900239 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.9 | 0.9 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.9 | 1.7 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
0.9 | 6.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.9 | 1.7 | GO:0086103 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.9 | 26.7 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.9 | 1.7 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
0.9 | 2.6 | GO:1901862 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle tissue development(GO:1901862) |
0.9 | 2.6 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.8 | 1.7 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.8 | 9.3 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.8 | 2.5 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
0.8 | 2.5 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.8 | 24.0 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.8 | 2.5 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
0.8 | 17.1 | GO:0010447 | response to acidic pH(GO:0010447) |
0.8 | 4.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.8 | 2.4 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.8 | 2.4 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.8 | 1.6 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.8 | 1.6 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.8 | 0.8 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.8 | 8.1 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.8 | 4.8 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.8 | 4.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.8 | 16.9 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.8 | 4.8 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.8 | 5.6 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
0.8 | 3.9 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.8 | 5.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.8 | 2.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.8 | 1.5 | GO:0035106 | operant conditioning(GO:0035106) |
0.8 | 1.5 | GO:0046636 | negative regulation of alpha-beta T cell activation(GO:0046636) |
0.8 | 4.6 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.8 | 1.5 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.8 | 6.0 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
0.8 | 2.3 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.8 | 6.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.7 | 3.7 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.7 | 2.2 | GO:0036507 | protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) endoplasmic reticulum mannose trimming(GO:1904380) |
0.7 | 2.2 | GO:1904616 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.7 | 7.4 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
0.7 | 2.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.7 | 4.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.7 | 5.1 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.7 | 5.1 | GO:1903232 | melanosome assembly(GO:1903232) |
0.7 | 1.5 | GO:0061010 | gall bladder development(GO:0061010) |
0.7 | 2.9 | GO:0000023 | maltose metabolic process(GO:0000023) |
0.7 | 10.8 | GO:0050708 | regulation of protein secretion(GO:0050708) |
0.7 | 12.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.7 | 4.3 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.7 | 11.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.7 | 2.8 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.7 | 4.9 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.7 | 2.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.7 | 2.8 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.7 | 4.1 | GO:0045471 | response to ethanol(GO:0045471) |
0.7 | 4.8 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.7 | 3.4 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.7 | 9.5 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.7 | 20.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.7 | 0.7 | GO:1905225 | response to thyrotropin-releasing hormone(GO:1905225) |
0.7 | 6.0 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.7 | 8.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.7 | 6.7 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.7 | 6.6 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.7 | 3.3 | GO:1901655 | cellular response to ketone(GO:1901655) |
0.7 | 17.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.7 | 0.7 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.7 | 3.9 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.7 | 1.3 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.7 | 1.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.6 | 32.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.6 | 2.6 | GO:0010813 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.6 | 4.5 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.6 | 1.3 | GO:2000553 |